Connect Biopharma Reports First Half 2024 Financial Results and Provides Business Update
CNTBnect Biopharma (CNTB) GlobeNewswire News Room·2024-09-06 04:05

Announced new U.S.-based leadership with the appointment of Barry Quart, Pharm.D. as Chief Executive Officer (CEO) and David Szekeres as PresidentConnect’s new management is currently evaluating the future clinical development strategy for rademikibartAs part of Connect’s transformation into a U.S.-centric company, the Company will be significantly reducing its presence in ChinaCash and cash equivalents of $110.2 million expected to support planned operations into at least the first half of 2027 SAN DIEGO, ...